AMD shares rise ahead of strong earnings forecast, outpacing sector and S&P 500
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Meta shares plunge after tax charge and higher costs warning
AMD shares rise ahead of strong earnings forecast, outpacing sector and S&P 500
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Meta shares plunge after tax charge and higher costs warning
